Selank


Overview

Selank is a synthetic heptapeptide derived from tuftsin, a natural immune-modulating peptide, developed at the Russian Academy of Sciences. It is approved in Russia as an anxiolytic — one of the very few peptides anywhere with a psychiatric indication — and is used intranasally.

Its profile is unusual: anti-anxiety effects without sedation, addiction potential or cognitive dulling — the problems that plague benzodiazepines.

How It Works

Selank modulates GABAergic transmission — the brain main inhibitory system — without directly binding benzodiazepine sites, which explains the calm-without-sedation profile. It also influences monoamine metabolism (serotonin, dopamine) and the expression of BDNF.

Immune dimension

As a tuftsin analogue, selank retains immunomodulatory properties, affecting cytokine balance. The Russian literature describes antiviral and immune-normalizing effects alongside the psychiatric ones — a reminder that the brain-immune interface is real biology, not marketing.

Key Benefits

Anxiety reduction — the approved Russian indication, with clinical trial support.

No sedation or dependence — the key differentiator from benzodiazepines.

Focus under stress — users report preserved or improved cognition where benzos would blunt it.

Immune modulation — documented in the Russian research literature.

Side Effects & Considerations

Intranasal selank is well tolerated; nasal irritation and mild fatigue are the main complaints. No dependence or withdrawal has been documented — a genuine advantage if the data holds.

Evidence boundaries

All clinical evidence is Russian and much of it is old by Western standards. Independent replication is lacking. Effects are described as subtle — a turning down of the anxiety dial rather than a switch. For diagnosed anxiety disorders, established treatments have far deeper evidence. Not approved outside Russia; intranasal peptide quality on the grey market varies.

Dosage protocols

Protocol Dosage Frequency Duration Notes
Standard (Russian protocol) 250-500 mcg (2-3 drops per nostril) 2-3 times daily 10-14 days, repeatable Intranasal. Effects build over the first days of a cycle.

Warnings

Not approved outside Russia. All clinical evidence is Russian. Subtle effects — not a replacement for established anxiety treatment.